Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HQL8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 215 | 219 | PF00656 | 0.507 |
CLV_C14_Caspase3-7 | 43 | 47 | PF00656 | 0.437 |
CLV_NRD_NRD_1 | 304 | 306 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 332 | 334 | PF00675 | 0.482 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.544 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.570 |
CLV_PCSK_PC1ET2_1 | 130 | 132 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.432 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.390 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 351 | 355 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.542 |
DEG_APCC_DBOX_1 | 12 | 20 | PF00400 | 0.515 |
DEG_APCC_KENBOX_2 | 347 | 351 | PF00400 | 0.524 |
DOC_MAPK_gen_1 | 175 | 183 | PF00069 | 0.526 |
DOC_MAPK_RevD_3 | 135 | 151 | PF00069 | 0.583 |
DOC_PP1_RVXF_1 | 177 | 184 | PF00149 | 0.331 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.335 |
DOC_USP7_MATH_1 | 327 | 331 | PF00917 | 0.393 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.515 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.572 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.633 |
DOC_USP7_UBL2_3 | 348 | 352 | PF12436 | 0.302 |
LIG_14-3-3_CanoR_1 | 131 | 135 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 136 | 141 | PF00244 | 0.434 |
LIG_14-3-3_CanoR_1 | 211 | 217 | PF00244 | 0.553 |
LIG_Actin_WH2_2 | 224 | 242 | PF00022 | 0.305 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.565 |
LIG_BRCT_BRCA1_1 | 342 | 346 | PF00533 | 0.389 |
LIG_BRCT_BRCA1_2 | 342 | 348 | PF00533 | 0.394 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.524 |
LIG_FHA_1 | 309 | 315 | PF00498 | 0.407 |
LIG_FHA_2 | 167 | 173 | PF00498 | 0.570 |
LIG_FHA_2 | 213 | 219 | PF00498 | 0.424 |
LIG_LIR_Nem_3 | 335 | 339 | PF02991 | 0.314 |
LIG_NRBOX | 143 | 149 | PF00104 | 0.589 |
LIG_NRBOX | 18 | 24 | PF00104 | 0.332 |
LIG_PCNA_yPIPBox_3 | 244 | 256 | PF02747 | 0.490 |
LIG_SH2_SRC | 216 | 219 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 325 | 329 | PF00017 | 0.293 |
LIG_SH2_STAT3 | 93 | 96 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.542 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.444 |
LIG_SH3_3 | 149 | 155 | PF00018 | 0.658 |
LIG_SUMO_SIM_par_1 | 251 | 259 | PF11976 | 0.327 |
LIG_TRAF2_1 | 169 | 172 | PF00917 | 0.521 |
LIG_TRAF2_1 | 52 | 55 | PF00917 | 0.476 |
LIG_UBA3_1 | 140 | 149 | PF00899 | 0.528 |
LIG_UBA3_1 | 194 | 198 | PF00899 | 0.397 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.542 |
MOD_CK1_1 | 207 | 213 | PF00069 | 0.427 |
MOD_CK1_1 | 275 | 281 | PF00069 | 0.693 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.660 |
MOD_CK2_1 | 153 | 159 | PF00069 | 0.628 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.409 |
MOD_CK2_1 | 182 | 188 | PF00069 | 0.542 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.488 |
MOD_GlcNHglycan | 113 | 117 | PF01048 | 0.416 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.705 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.535 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.535 |
MOD_GlcNHglycan | 325 | 328 | PF01048 | 0.295 |
MOD_GSK3_1 | 207 | 214 | PF00069 | 0.477 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.505 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.559 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.540 |
MOD_LATS_1 | 32 | 38 | PF00433 | 0.350 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.504 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.576 |
MOD_NEK2_1 | 256 | 261 | PF00069 | 0.442 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.587 |
MOD_NEK2_1 | 323 | 328 | PF00069 | 0.480 |
MOD_NEK2_1 | 360 | 365 | PF00069 | 0.470 |
MOD_PIKK_1 | 233 | 239 | PF00454 | 0.301 |
MOD_PIKK_1 | 34 | 40 | PF00454 | 0.454 |
MOD_PIKK_1 | 50 | 56 | PF00454 | 0.600 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.654 |
MOD_PIKK_1 | 92 | 98 | PF00454 | 0.573 |
MOD_PKA_1 | 130 | 136 | PF00069 | 0.483 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.452 |
MOD_PKA_2 | 269 | 275 | PF00069 | 0.671 |
MOD_PKB_1 | 175 | 183 | PF00069 | 0.500 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.487 |
MOD_Plk_1 | 211 | 217 | PF00069 | 0.462 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.403 |
MOD_Plk_1 | 319 | 325 | PF00069 | 0.457 |
MOD_Plk_1 | 340 | 346 | PF00069 | 0.511 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.459 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.436 |
MOD_SUMO_for_1 | 24 | 27 | PF00179 | 0.342 |
MOD_SUMO_for_1 | 309 | 312 | PF00179 | 0.472 |
MOD_SUMO_rev_2 | 254 | 262 | PF00179 | 0.449 |
MOD_SUMO_rev_2 | 343 | 353 | PF00179 | 0.523 |
TRG_DiLeu_BaEn_1 | 190 | 195 | PF01217 | 0.444 |
TRG_DiLeu_BaEn_1 | 234 | 239 | PF01217 | 0.526 |
TRG_ER_diArg_1 | 304 | 306 | PF00400 | 0.553 |
TRG_NES_CRM1_1 | 15 | 28 | PF08389 | 0.564 |
TRG_Pf-PMV_PEXEL_1 | 119 | 123 | PF00026 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 362 | 366 | PF00026 | 0.348 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAJ8 | Leptomonas seymouri | 63% | 100% |
A0A0S4KNY7 | Bodo saltans | 26% | 95% |
A0A1X0NLT9 | Trypanosomatidae | 35% | 98% |
A0A3Q8IQ67 | Leishmania donovani | 76% | 99% |
A0A422NVX8 | Trypanosoma rangeli | 37% | 98% |
A4ICD6 | Leishmania infantum | 76% | 99% |
D0A3S1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 98% |
E9AUD3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
Q4Q057 | Leishmania major | 74% | 100% |
V5BD37 | Trypanosoma cruzi | 32% | 98% |